BlackRock Japan’s Gyre Therapeutics GYRE Stock Holding History

BlackRock Japan’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18	Closed	-$2K	–	1333
2016 Q3	$2K	Sell	18 -1	-5%	-$151	﹤0.01%	1292
2016 Q2	$3K	Sell	19 -1	-5%	-$171	﹤0.01%	1372
2016 Q1	$4K	Sell	20 -1	-5%	-$241	﹤0.01%	1370
2015 Q4	$7K	Sell	21 -3	-13%	-$1.18K	﹤0.01%	1301
2015 Q3	$12K	Buy	+24	New	+$36.6K	﹤0.01%	1149
2014 Q1	–	Hold	0	–	-$1K	–	1421
2013 Q4	–	Hold	0	–	–	–	1330

Other funds holding GYRE

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return

CCM

Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Japan's GYRE Position: Q4 2016 in Review

BlackRock Japan sold out of Gyre Therapeutics (GYRE) in Q4 2016, closing a stake of 18 shares — an estimated $2K sold.

BlackRock Japan first reported a position in GYRE in Q3 2015 and held it in 5 quarters. The position peaked at $12K in Q3 2015. 27 funds tracked by Wall St. Rank hold GYRE as of Q4 2016.

BlackRock Japan reported no remaining Gyre Therapeutics position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 18 Gyre Therapeutics shares in Q4 2016, an estimated $2K.
BlackRock Japan first reported a position in Gyre Therapeutics in Q3 2015 and held it in 5 quarters.
BlackRock Japan's Gyre Therapeutics position peaked at $12K in Q3 2015.
27 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.